Kyntra Bio, Inc. (KYNB)

8.55 +0.06 (+0.71%) USD  |  NASDAQ  |  Sep 04, 16:00
8.55 0.00 (0.00%) After-Hours: 20:00
More

Kyntra Bio SG&A Expense (TTM) : 27.67M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for KYNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 27.67M
March 31, 2026 25.46M
December 31, 2025 27.71M
September 30, 2025 28.80M
June 30, 2025 41.06M
March 31, 2025 56.28M
December 31, 2024 71.00M
September 30, 2024 86.87M
June 30, 2024 94.89M
March 31, 2024 103.80M
December 31, 2023 115.25M
September 30, 2023 125.00M
June 30, 2023 129.32M
March 31, 2023 128.40M
December 31, 2022 124.69M
September 30, 2022 125.46M
June 30, 2022 121.41M
March 31, 2022 123.71M
December 31, 2021 123.92M
September 30, 2021 131.44M
June 30, 2021 56.60M
March 31, 2021 87.58M
December 31, 2020 106.41M
September 30, 2020 114.86M
June 30, 2020 199.67M
Date Value
March 31, 2020 162.87M
December 31, 2019 135.48M
September 30, 2019 102.62M
June 30, 2019 82.16M
March 31, 2019 70.47M
December 31, 2018 63.81M
September 30, 2018 59.81M
June 30, 2018 57.41M
March 31, 2018 55.78M
December 31, 2017 51.76M
September 30, 2017 50.49M
June 30, 2017 49.19M
March 31, 2017 46.14M
December 31, 2016 46.02M
September 30, 2016 46.40M
June 30, 2016 46.00M
March 31, 2016 45.30M
December 31, 2015 44.36M
September 30, 2015 44.22M
June 30, 2015 43.12M
March 31, 2015 40.96M
December 31, 2014 36.91M
September 30, 2014 29.24M
June 30, 2014 23.56M
March 31, 2014 16.04M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Vericel Corp. 180.98M
Capricor Therapeutics, Inc. 35.43M
ARS Pharmaceuticals, Inc. 284.49M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B